Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems.

Sunoqrot S, Bae JW, Jin SE, M Pearson R, Liu Y, Hong S.

Bioconjug Chem. 2011 Mar 16;22(3):466-74. doi: 10.1021/bc100484t. Epub 2011 Feb 23.

2.

In vitro evaluation of dendrimer-polymer hybrid nanoparticles on their controlled cellular targeting kinetics.

Sunoqrot S, Liu Y, Kim DH, Hong S.

Mol Pharm. 2013 Jun 3;10(6):2157-66. doi: 10.1021/mp300560n. Epub 2012 Dec 31.

3.

Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.

Essa S, Rabanel JM, Hildgen P.

Int J Pharm. 2011 Jun 15;411(1-2):178-87. doi: 10.1016/j.ijpharm.2011.02.039. Epub 2011 Mar 31.

PMID:
21458551
4.

On the synthesis of mucus permeating nanocarriers.

Bourganis V, Karamanidou T, Samaridou E, Karidi K, Kammona O, Kiparissides C.

Eur J Pharm Biopharm. 2015 Nov;97(Pt A):239-49. doi: 10.1016/j.ejpb.2015.01.021. Epub 2015 Feb 3.

PMID:
25661586
5.

Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

Hadinoto K, Sundaresan A, Cheow WS.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Review.

PMID:
23872180
6.

Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.

Sant S, Poulin S, Hildgen P.

J Biomed Mater Res A. 2008 Dec 15;87(4):885-95. doi: 10.1002/jbm.a.31800.

PMID:
18228249
7.

Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles.

Sunoqrot S, Bae JW, Pearson RM, Shyu K, Liu Y, Kim DH, Hong S.

Biomacromolecules. 2012 Apr 9;13(4):1223-30. doi: 10.1021/bm300316n. Epub 2012 Mar 30.

8.

Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.

Mattu C, Pabari RM, Boffito M, Sartori S, Ciardelli G, Ramtoola Z.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):463-72. doi: 10.1016/j.ejpb.2013.07.016. Epub 2013 Aug 1.

PMID:
23916461
9.

Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.

Zhang J, Li Y, Gao W, Repka MA, Wang Y, Chen M.

Expert Opin Drug Deliv. 2014 Sep;11(9):1367-80. doi: 10.1517/17425247.2014.924503. Epub 2014 Jun 16. Erratum in: Expert Opin Drug Deliv. 2015 Apr;12(4):689.

PMID:
24935153
10.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

Le Droumaguet B, Nicolas J, Brambilla D, Mura S, Maksimenko A, De Kimpe L, Salvati E, Zona C, Airoldi C, Canovi M, Gobbi M, Magali N, La Ferla B, Nicotra F, Scheper W, Flores O, Masserini M, Andrieux K, Couvreur P.

ACS Nano. 2012 Jul 24;6(7):5866-79. doi: 10.1021/nn3004372. Epub 2012 Jul 2.

PMID:
22725248
11.

Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.

Yang Z, Luo X, Zhang X, Liu J, Jiang Q.

Biomed Mater. 2013 Apr;8(2):025012. doi: 10.1088/1748-6041/8/2/025012. Epub 2013 Mar 18.

PMID:
23507576
12.

Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.

Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M.

Mol Pharm. 2014 Mar 3;11(3):859-71. doi: 10.1021/mp400536z. Epub 2014 Jan 27.

PMID:
24410438
13.

Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.

Huh MS, Lee SY, Park S, Lee S, Chung H, Lee S, Choi Y, Oh YK, Park JH, Jeong SY, Choi K, Kim K, Kwon IC.

J Control Release. 2010 Jun 1;144(2):134-43. doi: 10.1016/j.jconrel.2010.02.023. Epub 2010 Feb 22.

PMID:
20184928
14.

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.

Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC.

Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.

PMID:
19111339
15.

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

Feng SS, Mei L, Anitha P, Gan CW, Zhou W.

Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

PMID:
19299012
16.

Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.

Doggui S, Sahni JK, Arseneault M, Dao L, Ramassamy C.

J Alzheimers Dis. 2012;30(2):377-92. doi: 10.3233/JAD-2012-112141.

PMID:
22426019
17.

Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.

Chen J, Li S, Shen Q, He H, Zhang Y.

Drug Dev Ind Pharm. 2011 Nov;37(11):1339-46. doi: 10.3109/03639045.2011.575162. Epub 2011 Apr 27.

PMID:
21524153
18.

Preparation of biodegradable nanoparticles and their use in transfection.

Vasir JK, Labhasetwar V.

CSH Protoc. 2008 Jan 1;2008:pdb.prot4888. doi: 10.1101/pdb.prot4888.

PMID:
21356670
19.

Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.

Jain S, Spandana G, Agrawal AK, Kushwah V, Thanki K.

Mol Pharm. 2015 Nov 2;12(11):3871-84. doi: 10.1021/acs.molpharmaceut.5b00281. Epub 2015 Oct 1.

PMID:
26375023
20.

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.

Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM.

J Control Release. 2008 Feb 11;125(3):193-209. Epub 2007 Oct 22. Review.

PMID:
18083265

Supplemental Content

Support Center